Remove 2023 Remove Biopharma Remove Collaboration
article thumbnail

Leadership in Biopharma: Key thought leaders in the Biopharma industry

Jake Jorgovan

The Biopharma industry is always evolving. However, thought leaders in the Biopharma industry offer innovative insights and strategic direction. You're on the right page to find these experts; we’ll discuss Biopharma's top 12 thought leaders, highlighting their unique expertise and what they can teach you. Let’s dive in.

Biopharma 130
article thumbnail

Emergent Challenges in Biopharma Portfolio Management

Planview Blog

In 2023, Planview was pleased to sponsor several WHY Summit Events: Basil, Switzerland, and Philadelphia. R evisit WHY Summit 2023 in this blog What is WHY Summit The WHY Summit brings together project, program, and portfolio management professionals from the pharmaceutical and healthcare industries.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 10 Strategic Imperatives Driving Innovation in AI-Enhanced Drug Discovery and Development

Frost & Sullivan

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% However, the pharma/biopharma industry overall shows stagnant R&D activity. growth from 2023 to 2024. increase from 2022. Total R&D expenditure is approximately $276.81

article thumbnail

Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?

Frost & Sullivan

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% However, the pharma/biopharma industry shows overall stagnant R&D activity. growth from 2023 to 2024. What is driving transformation in the pharma industry? increase from 2022.

article thumbnail

BTD BRINGS M&A DISCIPLINES TO ASAP

BTD Consulting

The sponsorship agreement, which begins this year, will continue through 2023 and beyond. Over the past 20 years, alliances have shown the power of collaboration. Alliance managers have become masters of high-stakes collaboration. ASAP and its members have led this success.

article thumbnail

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Frost & Sullivan

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. years, to become a truly global company with a diverse mix of public sector and biopharma clients. SAN ANTONIO, TX.

article thumbnail

BTD brings M&A to ASAP

BTD Consulting

The sponsorship agreement, which begins this year, will continue through 2023 and beyond. Over the past 20 years, alliances have shown the power of collaboration. Alliance managers have become masters of high-stakes collaboration. ASAP and its members have led this success.